Ceramide is a sphingolipid that serves as an important second messenger in an increasing number of stress-induced pathways. Ceramide has long been known to affect the mitochondria, altering both morphology and physiology. We sought to assess the impact of ceramide on skeletal muscle mitochondrial structure and function. A primary observation was the rapid and dramatic division of mitochondria in ceramide-treated cells. This effect is likely to be a result of increased Drp1 (dynamin-related protein 1) action, as ceramide increased Drp1 expression and Drp1 inhibition prevented ceramide-induced mitochondrial fission. Further, we found that ceramide treatment reduced mitochondrial O 2 consumption (i.e. respiration) in cultured myotubes and permeabilized red gastrocnemius muscle fibre bundles. Ceramide treatment also increased H 2 O 2 levels and reduced Akt/PKB (protein kinase B) phosphorylation in myotubes. However, inhibition of mitochondrial fission via Drp1 knockdown completely protected the myotubes and fibre bundles from ceramide-induced metabolic disruption, including maintained mitochondrial respiration, reduced H 2 O 2 levels and unaffected insulin signalling. These data suggest that the forced and sustained mitochondrial fission that results from ceramide accrual may alter metabolic function in skeletal muscle, which is a prominent site not only of energy demand (via the mitochondria), but also of ceramide accrual with weight gain.
INTRODUCTION
The current worldwide trends of increasing prevalence of obesity and Type 2 diabetes suggest the complexity of the problem and the need for intensive research to discover effective therapeutic interventions. The perfect metabolic storm of dietary excess, poor nutrient quality and reduced physical activity combine to increase the risk of developing insulin resistance, which is not only the foundation of Type 2 diabetes, but is also a contributing cause and consequence of obesity [1, 2] . These causal factors (i.e. poor diet and sedentary living) lead to two distinct theories regarding the aetiology of obesity-induced metabolic disruption, namely altered mitochondrial function and ceramide accumulation.
Despite being commonly represented as small segmented structures, mitochondria are highly dynamic organelles undergoing continuous fission and fusion. Indeed, the word mitochondrion itself reveals the typical state of the mitochondrion (mitos means thread) as reticular rather than segmented. Increasingly, evidence suggests that mitochondrial structure determines mitochondrial function [3] , including substrate metabolism [4, 5] and mitochondrial bioenergetics [6] . Given that obesity and Type 2 diabetes have been considered a malady of maladaptive mitochondria, it is not surprising that interventions to stimulate mitochondrial fission or fusion elicit disparate effects on metabolic function, such as mitochondrial respiration [6] and insulin signalling [5] . A consensus suggests mitochondrial fusion as beneficial in maintaining insulin sensitivity and resisting fat gain with dietary challenge [4, 5] .
In addition to altered mitochondrial function, the second factor that may explain obesity-induced metabolic disruption is the accumulation of the sphingolipid ceramide. Ceramide is known to accumulate in insulin-sensitive [7] , as well as highmetabolic-rate, organs [7] [8] [9] [10] , eliciting a potentially powerful impact on whole-body metabolic function. Ceramide is known to induce insulin resistance via decayed Akt/PKB (protein kinase B) phosphorylation, as well as to increase the generation of mitochondria-derived ROS (reactive oxygen species) [11, 12] , which are increased with mitochondrial fission [13] .
With these two distinct theories in mind (i.e. altered mitochondrial function and ceramide accrual), we sought to test the unifying hypothesis that ceramide forces mitochondrial fission, which is a critical mediator of ceramide-induced metabolic disruption. In support of this hypothesis, we observed that exogenous and endogenous ceramide levels increased mitochondrial fission in cultured cells via Drp1 (dynaminrelated protein 1). Increased fission was associated with reduced mitochondrial respiration, likely at complex II, and increased production of ROS. Moreover, we found that mitochondrial fission is important in ceramide-induced insulin resistance, as cells co-treated with a Drp1 inhibitor maintained insulin signalling despite the presence of ceramide. Lastly, mice fed a HFHS (high-fat high-sugar) diet experienced glucose and Abbreviations used: C2, C 2 -ceramide; DMEM, Dulbecco's modified Eagle's medium; Drp1, dynamin-related protein 1; ER, endoplasmic reticulum; EtOH, ethanol; ETS, electron-transport system; FCCP, carbonyl cyanide p-trifluoromethoxyphenylhydrazone; GM, glutamate + malate; HFD, high-fat diet; HFHS, high-fat high-sugar; HRP, horseradish peroxidase; KRPG, Krebs-Ringer phosphate glucose; Mdivi-1, mitochondrial division inhibitor 1; Mfn2, mitofusin 2; NAC, N-acetylcysteine; PA, palmitate; PKB, protein kinase B; RG, red gastrocnemius; ROS, reactive oxygen species; Rot, rotenone; SD, standard diet; sptlc2/SPT2, serine palmitoyltransferase, long chain base subunit 2; SUIT, substrate-uncoupler-inhibitor-titration. 1 To whom correspondence should be addressed (email benjamin_bikman@byu.edu).
insulin intolerance relative to SD (standard diet)-fed mice and HFHS-fed mice supplemented with myriocin to inhibit serine palmitoyltransferase, the rate-limiting enzyme in ceramide biosynthesis. Moreover, the myriocin-treated HFHS-fed mice did not gain excess weight. Additionally, mitochondrial respiration was partially blunted in the RG (red gastrocnemius) muscle of the HFHS-fed mice, but not of those receiving myriocin. In the end, the present study suggests the potential efficacy of therapies that reduce excess ceramide accrual and/or prevent ceramideinduced mitochondrial fission in the treatment of obesity and insulin resistance.
MATERIALS AND METHODS

Animals
Male C57Bl/6 mice were separated at 8 weeks into one of four treatment groups for 12 weeks: (i) SD (Harlan 
Cell culture
C2C12 murine myoblast cells were maintained in DMEM (Dulbecco's modified Eagle's medium) plus 10 % FBS (Invitrogen). For differentiation into myotubes, C2C12 myoblasts were grown to confluency and the medium was replaced with DMEM plus 10 % horse serum (Invitrogen). Myotubes were used for experiments on day 4 of differentiation. For fatty acid treatment, palmitic acid (Sigma-Aldrich; catalogue number P5585) was dissolved in EtOH (ethanol) and diluted to the desired concentration in DMEM containing 2 % (w/v) BSA (SigmaAldrich; A9576) and added to the cell culture at 0.5 mM, which is a physiological post-prandial fatty acid concentration [15] . For ceramide treatment, C2 (C 2 -ceramide; N-acetyl-D-sphingosine; Sigma-Aldrich; A7191) was diluted in EtOH in a 10 mM stock solution. For Mdivi-1 (mitochondrial division inhibitor 1) treatment, Mdivi-1 (Sigma-Aldrich; M0199) was diluted in DMSO in a 50 mM stock solution. For sptlc2 (serine palmitoyltransferase, long chain base subunit 2; also known as SPT2) knock down, procedures were followed according to the manufacturer's instructions (Santa Cruz Biotechnology; sc-77377).
Lipid analysis
For isolation of lipids, pellets were re-suspended in 900 μl of icecold chloroform/methanol (1:2), incubated for 15 min on ice, then briefly vortex-mixed. Separation of aqueous and organic phases required addition of 400 μl of ice-cold water and 300 μl of icecold chloroform. (tandem MS) fragmentation data were also collected and manually verified for each mass window to give additional confidence to the correct identification of abundant lipid species. Three technical replicate mass spectrometer runs were performed on each sample. Samples were injected at 10 μl/min using a direct-inject ESI softionization spray head from a Hamilton GASTIGHT glass syringe. The spray voltage and capillary temperature were maintained at 5.0 kV and 275 • C respectively. Each technical replicate was run in random order to reduce systematic bias. Data were analysed using in-house-developed peak summarization, recalibration and lipid identification software using lipid database information from the Lipid MAPS (LIPID Metabolites and Pathways Strategy) Lipidomics Gateway database [16] . To ensure high-confidence identifications, an intensity threshold estimated to be 5 % above the instrumental static signal was implemented. Lipid identities were only assigned when significantly observable peaks were identified in at least two of the three technical replicate runs. Non-zero lipid quantities were averaged from the replicate runs. The lipid species identified across different ionization states or with adducts were totalled together. Quantification was completed by normalizing total ion counts to the relative abundance of the internal standard that was spiked into each sample.
Mitochondrial morphology
C2C12 myoblasts were grown to confluence in chamber slides (NUNC Lab-Tek II Chambered Coverglass System; 155382) and differentiate at day 4. The mitochondrial dye MitoTracker Red CMXRos (Molecular Probes; M7512), dissolved in anhydrous DMSO, was added to cultured myotubes at a concentration of 250 nM. The cells were incubated for 30 min at 37
• C in the dark and then visualized using a confocal microscope (Olympus IX81). For muscle mitochondrial imaging, the RG muscle was extracted and fixated in 0.1 M sodium cacodylate and 3 % gluteraldehyde at pH 7.3 for 3 h. The tissues were washed in 0.1 M sodium cacodylate (six times for 10 min) and then washed in ddH 2 O (double-distilled water; six times for 10 min). Postfixation occurred in 1 % OsO 4 (0.1 M for 2h at 22
• C). The samples were then soaked overnight in 0.5 % uranyl acetate at 4
• C. The tissues were dehydrated in a graded series of acetone (10 min steps of 10 %, 30 %, 50 %, 70 %, 95 % and 100 % three times) then embedded in Spurrs ® resin. Ultrathin sections (90 nm thick) were cut with a microtome and diamond blade then stained with 0.4 % lead citrate. The samples were then imaged with transmission electron microscopy.
Quantitative real-time PCR
Total RNA was extracted and purified from tissues using TRIzol ® (Invitrogen) according to the manufacturer's recommendations. cDNA was synthesized from mRNA via reverse transcription-PCR using a commercial cDNA synthesis kit with oligo(dT) primers (iScript Select cDNA Synthesis; Bio-Rad Laboratories). Quantitative real-time PCR was performed with Evagreen Ssofast (Bio-Rad Laboratories) using a Bio-Rad Laboratories CFX Connect Real-Time PCR Detection system. Primer sequences were 5 -ACAGGATGCAGAAGGAGATTAC-3 and 5 -CA-CAGAGTACTTGCGCTCAGGA-3 as the forward and reverse primers respectively for actin, 5 -ACTTGACCTCCCTACTGGC-3 and 5 -TCCTCTATCCCGTTGACACC-3 as the forward and reverse primers respectively for Drp1, and 5 -AA-GTCCGGGAAGCTGAAAGT-3 and 5 -TCTCGGTTATGG-AACCAACC-3 as the forward and reverse primers respectively for Mfn2 (mitofusin 2). β-Actin reactions were performed side by side with every sample analysed. Changes in the mRNA level of each gene for each treatment were normalized to that of the β-actin control mRNA according to Pfaffl [17] .
Protein analysis
Tissue and cell extracts lysed and protein content was determined using a BCA protein assay (Pierce) and the sample volumes were adjusted so that precisely 50 μg of protein was loaded into each lane. After the addition of sample buffer, samples were resolved by SDS/PAGE (10 % gel), transferred on to nitrocellulose membranes and immunoblotted using methods described previously [18] . After incubation with primary antibody, blots were incubated with an HRP (horseradish peroxidase)-conjugated secondary antibody. HRP activity was assessed with ECL solution (Thermo Scientific) and exposed to film. The primary antibodies used were: anti-SPT2 (Abcam; ab23696), anti-phospho-Akt (Cell Signaling Technology; 4058S), anti-Akt/PKB (Sigma-Aldrich; 217005), the OxPhos Complex Kit (Invitrogen; 457999) and anti-actin (Cell Signaling Technology; 8457S). The secondary antibodies used were: anti-(mouse IgG) (Cell Signaling Technology; 7076S) and anti-(rabbit IgG) (Cell Signaling Technology; 7074S).
Cell and muscle fibre bundle permeabilization
For the cells, C2C12 myotubes were detached in culture dishes with 0.05 % trypsin/EDTA (Sigma) and growth medium was added to the culture. Contents were transferred into a tube and centrifuged for 10 min at 1500 g at room temperature (25 • C). After removal of the supernatant, cells were resuspended in mitochondrial respiration buffer 05 [MiR05; 0.5 mM EGTA, 10 mM KH 2 PO 4 , 3 mM MgCl 2 ·6H 2 O, 60 mM K-lactobionate, 20 mM Hepes, 110 mM sucrose and 1 mg/ml fatty-acid-free BSA (pH 7.1)] plus 1 mg/ml digitonin and gently rocked at room temperature for 5 min before centrifugation at 10 min at 1500 g for 5 min. After discarding the supernatant, cells were then suspended in 2.2 ml of warm MiR05 and transferred into chambers in a O2K respirometer (Oroboros Instruments). Following the respiration protocol (outlined below), cells were removed from the chambers and used for further analysis, including protein quantification. For skeletal muscle use, the RG muscle was quickly removed from mice following cervical dislocation and immediately placed in ice-cold buffer X [60 mM K-Mes, 35 • C for at least 15 min.
Mitochondrial respiration
High-resolution O 2 consumption was determined at 37
• C in permeabilized cells (MiR05) and fibre bundles (buffer Z) using the Oroboros Instruments O2K oxygraph. Before the addition of the samples into the respiration chambers, a baseline respiration rate was determined. After addition of the sample, the chambers were hyperoxygenated to ∼350 nmol/ml. Following this, respiration was determined according to two SUIT (substrate-uncouplerinhibitor titration) protocols [5] . For SUIT1, to determine the general electron transport system function, electron flow through complex I was supported by GM (glutamate + malate; 10 and 2 mM respectively) to determine O 2 consumption from proton leak (GM L ). Following stabilization, ADP (2.5 mM) was added to determine oxidative phosphorylation capacity (GM P ). The integrity of the outer mitochondrial membrane was then tested by adding cytochrome c (10 μM; GMc P ). Succinate was added (GMS P ) for complex I + II electron flow into the Qjunction. To determine the full ETS (electron-transport system) capacity over oxidative phosphorylation, the chemical uncoupler FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone) was added (0.05 μM, followed by 0.025 μM steps until maximal O 2 flux was reached). Complex II-supported ETS was then measured by inhibiting complex I with Rot (rotenone; 0.5 μM). Lastly, residual O 2 consumption was measured by adding antimycin A (2.5 μM) to block complex III action, effectively stopping any electron flow. This provides a rate of respiration that is used as a baseline and all presented values are controlled for by using this baseline. SUIT2 was used to determine complex II-specific respiration. This SUIT involved succinate (10 mM) with the addition of Rot (0.5 μM), for complex II-mediated leak respiration [S(Rot) L ], and then ADP (2.5 mM), for complex IImediated oxidative phosphorylation. Lastly, maximal ETS was determined by the addition of FCCP as above. Similarly, residual O 2 consumption was determined by antimycin A (2.5 μM) addition and all values were controlled for using this value. 
Statistics
Data are presented as means + − S.E.M. Data were compared by ANOVA with Tukey's post-hoc analysis (Graphpad Prism). Significance was set at P < 0.05.
RESULTS
Ceramide increases mitochondrial fission via Drp1
Drp-1 is a mitochondrial fission protein that induces outer membrane 'pinching' in the division of tubular mitochondria. Drp1 mRNA expression was significantly increased in C2C12 myotubes within 4 h of C2 (20 μM) treatment, and peaked after 8 h with a 3-fold increase compared with the baseline (Figure 1B) . Further, C2 treatment (20 μM) caused mitochondrial fission in mouse C2C12 myotubes after 16 h of treatment ( Figure 1A) . However, pre-treatment with Mdivi-1, an inhibitor of Drp1 [19] , prevented mitochondrial fission ( Figure 1A) . Functionally, C2-induced mitochondrial fission led to significantly reduced complex II-supported respiration (GMS P ), as determined by O 2 consumption in permeabilized C2C12 myotubes in the presence of glutamate, malate, succinate and ADP ( Figure 1C ). This was completely prevented by the co-treatment of Mdivi-1 in cell culture ( Figure 1C) .
To further confirm the effect of ceramide on mitochondrial fission, we explored the role of endogenously produced ceramides in response to fatty acid treatment. Accordingly, the sptlc2 gene was knocked down via siRNA (Santa Cruz Biotechnology) to prevent ceramide biosynthesis. Complete loss of the SPT2 protein was found at 120 h ( Figure 2A ) and subsequent experiments occurred at this time. The functionality of knock down was confirmed by the observed prevention of increased ceramide accrual with PA (palmitate) treatment ( Figure 2B ). Similar to ceramide treatments, PA resulted in mitochondrial fission ( Figure 2C ). Drp1 gene expression was elevated approximately 3-fold in the PA-treated cells, but not in SPT2-knockdown cells ( Figure 2D) , suggestive of the importance of ceramide in Drp1 expression. Moreover, mitochondria in cells lacking SPT2 were more fused than control cells receiving PA ( Figure 2C ). Although not as dramatic as in C2-treated cells, PA treatment also blunted respiration from complex-II-supported oxidative phosphorylation (GMS P ; Figure 2E ).
Ceramide inhibits complex II-supported mitochondrial respiration
Given our observations of a preferentially greater inhibition of complex II-supported mitochondrial respiration with ceramide treatment, we sought to elucidate this effect more directly. Accordingly, C2C12 myotubes were treated overnight with C2 or vehicle (EtOH). Although no significant difference was observed with succinate and Rot alone to determine leak respiration [S(Rot) L ], the addition of ADP to induce oxidative phosphorylation elicited a robust increase in respiration in vehicletreated cells that was less evident in ceramide-treated cells ( Figure 3A) . The same discrepancy was observed with the addition of the uncoupler FCCP, which collapses the chemiosmotic gradient via proton transport. This change in complex II-supported respiration occurred independent of a change in the amount of complex II ( Figure 3B , CII -Fp subunit).
Inhibition of mitochondrial fission prevents reduced mitochondrial respiration with ceramide ex vivo
Next, we sought to replicate our findings in whole muscle. Accordingly, the RG muscle was dissected from C57Bl6 mice and permeabilized. After permeabilization, fibre bundles were washed and placed in oxygraph sample chambers (O2K, Oroboros Instruments) filled with 2 ml of buffer Z and vehicle (EtOH) or C 16 -ceramide (20 μM). Further analyses included the addition of Mdivi-1 to inhibit Drp1-mediated mitochondrial fission. Upon placement in the chambers, fibre bundles were incubated in the buffer at 37
• C for 10 min. Following this, respiration was determined according to the indicated SUIT protocol [5] . We observed a significant increase in leak respiration (GM L ) in those fibres treated with Mdivi-1, although this difference did not linger with the addition of ADP (Figure 4) . We are not the first to note increased proton-leak-dependent respiration with increased mitochondrial fusion [20] . In contrast with Mdivi-1 treatment, ceramide-treated muscle fibre bundles exhibited a significantly blunted respiration with complex I-and II-supported respiration. No effect was observed when fibre bundles were treated with C2 or C 6 -ceramide (results not shown).
Mitochondrial fission is necessary for ceramide-induced ROS generation and insulin resistance in muscle
Mouse myotubes were treated with C2 or PA in the presence or absence of Mdivi-1 for 12 h. Following treatment, cells were washed with PBS and exposed to Amplex Red to quantify H 2 O 2 production. Although C2 alone elicited an increase in fluorescence with Amplex Red treatment, this effect was mitigated by inhibition of mitochondrial fission by Mdivi-1 co-treatment ( Figure 5A ). Considering the evidence suggesting redox-sensitive phosphorylation events in the regulation of the insulin signalling pathway [21] , we explored the effect of blocking mitochondrial fission, with its subsequent reduction in H 2 O 2 formation, on muscle insulin signalling. Inhibition of mitochondrial fission with Mdivi-1 protected Akt/PKB phosphorylation with insulin stimulation in C2-treated myotubes ( Figure 5B ).
ROS generation is not necessary for mitochondrial fission or altered mitochondrial respiration with PA and ceramide treatments
To address whether ROS are necessary for the mitochondriaspecific effects of both ceramide and PA, we replicated earlier experiments with the addition of the glutathione precursor NAC (N-acetylcysteine), an effective reducing agent known to neutralize H 2 O 2 [22, 23] . We found that C2-treated cells that were pre-treated with NAC appeared to experience a similar degree of mitochondrial fission as the C2 treatment alone ( Figure 6A ). Functionally, NAC pre-treatment likewise failed to prevent reduced mitochondrial respiration in ceramide-and PAtreated myotubes ( Figures 6B and 6C respectively) .
Inhibition of ceramide biosynthesis prevents metabolic disruption with dietary challenge
Male 8-week-old C57Bl6 mice were separated into one of four treatment groups for 12 weeks: (i) SD, (iii) HFHS diet, (iii) SD with myriocin (SD + Myr) and (iv) HFHS diet with myriocin (HFHS + Myr). No differences in food or water consumption were noted between the SD and SD + Myr groups and the HFHS and HFHS + Myr groups, although both the HFHS and HFHS + Myr groups consumed more water than the SD groups (results not shown). Marked differences in body weight were noted early in the dietary intervention, which lingered until the conclusion of the study period. Specifically, the HFHS group, but not the HFHS + Myr group, gained significantly greater body weight over the course of the study ( Figure 7A) . Further, the HFHS group experienced a significant reduction in glucose and insulin tolerance, but the HFHS + Myr group did not have a reduced response ( Figures 7B and 7C respectively) .
Owing to insufficient samples of RG muscle, full statistical analyses were not performed for ceramides and Drp1 expression in the RG. Thus, to determine the effect of intervention in a similarly highly oxidative mitochondria-rich tissue, the soleus
Figure 8 Skeletal muscle ceramide levels with treatments
Ceramides were measured in the RG (A) and soleus (B) muscles. Owing to a shortage of samples, statistical analysis was not possible for the RG muscle (n = 2-3). As a surrogate for RG muscle, levels of ceramide were analysed in the soleus muscle, which is a similarly highly oxidative muscle fibre type. Ceramide levels were significantly elevated in the soleus muscle after the HFHS compared with the SD treatment (n = 6). Although the reduction in ceramides was not significant with the addition of myriocin (Myr) in the HFHS group, the trend is suggestive of an effect. *P < 0.05 for the HFHS compared with the SD.
muscle was used as a surrogate for a complimentary analysis. Both muscles are commonly used in analyses of muscle mitochondrial capacity [24] . Ceramide levels were significantly elevated in the soleus of the HFHS group compared with the SD groups, but not in the HFHS + Myr group ( Figure 8B ). As mentioned above, statistical analysis of RG ceramide levels ( Figure 8A ) was not possible, although a trend appears to suggest a difference exists. Analysis of Drp1 expression in the soleus muscle revealed a robust increase in Drp1 expression with the HFHS diet over the other groups ( Figure 9B ), suggesting a role for Drp1 in mediating diet-induced mitochondrial fission. A lack of tissue for RG muscle analysis prevented statistical analysis, although the given data suggested a similar trend in the RG as noted in the soleus muscle ( Figure 9A ). Analysis of mitochondrial O 2 consumption in permeabilized muscle (RG) fibre bundles revealed a selective reduction in respiration in the HFHS group ( Figure 9C) . Specifically, both myriocin-treated groups had slightly higher leak respiration in the presence of GM alone (GM L ). This trend of myriocin to increase respiration continued to various degrees throughout the protocol, but was most apparent in the HFHS group. Moreover, respiration was blunted with both complex I-and II-mediated oxidative phosphorylation, although the difference was once again amplified with complex II-supported respiration. A portion of each RG muscle was prepared for electron microscopy to determine mitochondrial morphology with the various interventions (Figure 10) . Little difference in size of both the subsarcolemmal (Figure 10 , left-hand panels) and intramyofibrillar ( Figure 10 , right-hand panels) mitochondrial populations was noted between the SD-fed animals ( Figure 10A ) and those with myriocin supplementation ( Figure 10B ). In contrast, the HFHS diet appeared to result in markedly smaller and more segmented mitochondria than the SD groups ( Figure 10C ). However, long-term treatment of HFHS-fed animals with myriocin prevented this ( Figure 10D ). In particular, the subsarcolemmal mitochondria in the RG from the HFHS + Myr group appeared larger than those from any other group.
DISCUSSION
The basic conclusion of the present study is that division of the cellular mitochondrial network in muscle cells mediates the reduced mitochondrial respiration and loss of insulin signalling that accompanies ceramide accumulation. Given the widespread finding of skeletal muscle ceramide accumulation with weight gain [8, [25] [26] [27] , this conclusion invites a novel perspective in understanding the observations that defective mitochondrial fusion may cause, exacerbate, or is certainly related to, obesity and insulin resistance [4, 5, 20, 28, 29] .
The metabolic ramifications of the physical structure of mitochondria have appropriately received more attention in recent years and may assist in understanding metabolic disruption with obesity. Indeed, mitochondrial morphology may be relevant in the altered fuel handling evident in the muscle of obese and diabetic humans. The observation by Kelley et al. [30, 31] of a 'metabolic inflexibility' in obese and diabetic subjects stemmed from the inability of these subjects to oxidize glucose when provided with a glucose load. Interestingly, these same groups of subjects have been found to carry reduced proteins that drive mitochondrial fusion, namely Mfn2 [20, 28, 32] . A lack or overexpression of Mfn2 decreases or increases glucose oxidation respectively [33] . Thus the observed metabolic inflexibility with obesity/diabetes may in reality stem from a shift towards mitochondrial fission and reduced mitochondrial fusion. Although our report focuses on Drp1, which we consistently found elevated in response to ceramide, we have also explored the effect of ceramide on Mfn2. Whereas the HFHS diet had no effect on soleus muscle Mfn2 expression, myriocin supplementation had a dramatic effect. Mfn2 expression was increased significantly in both the SD + Myr and HFHS + Myr groups (Supplementary Figure  S1 at http://www.biochemj.org/bj/456/bj4560427add.htm). It is tempting to speculate that ceramide accumulation in skeletal muscle would force mitochondrial fission, which would subsequently result in reduced mitochondrial capacity and function, as well as insulin resistance, ultimately exacerbating weight gain.
Myriocin is usually administered every 24-48 h by intraperitoneal injection. Given the efficacy of oral myriocin supplementation, the findings of the present study reveal a novel and effective delivery method for myriocin. Regardless of the delivery, ceramide inhibition with myriocin has consistently led to an improved metabolic profile and resistance to metabolic insults, such as diet-induced obesity. Indeed, we observed a similar resistance to the deleterious effects of dietary challenge on glucose and insulin tolerance as that noted by the Lopaschuk and co-workers [34] . Moreover, it is tempting to speculate that the reduced whole-body O 2 consumption in the HFD (highfat diet) group, but not in the myriocin-treated HFD group, in their study [34] is partly a result of the more dramatic and disparate O 2 consumption rates we observed in permeabilized ceramide-depleted and -replete muscle cells and fibre bundles
Figure 9 Ceramide inhibition protects diet-induced alterations in mitochondrial function
Drp1 expression was determined in the RG (A) and soleus (B) muscles from mice following a 12 week dietary intervention. Owing to insufficient samples of RG muscles (n = 2-3), the soleus muscle was used as a surrogate (n = 6). Mice fed a HFHS diet expressed significantly higher levels of Drp1 in the soleus muscle than all other groups. (C) O 2 consumption was determined in permeabilized RG muscles from the four dietary interventions using SUIT1 (see the Materials and methods section for details) (n = 6). *P < 0.05 for the HFHS diet compared with the SD. #P < 0.05 for HFHS diet and myriocin compared with the HFHS diet alone.
( Figures 1, 2, 4 and 8) . We also noted a lack of body weight gain with myriocin supplementation in spite of an HFHS diet intervention ( Figure 8A ). These results support similar findings of an obesity-resistant effect of myriocin [35] and other inhibitors of ceramide biosynthesis [36] , be they pharmacological [37] or genetic [38] .
The results from the present study support those by Jheng et al. [5] that recently explored the effect of lipid overload and dietary challenge on mitochondrial fission and function. Although they did not elucidate the role of ceramides, Jheng et al. [5] found that PA, but not unsaturated oleate, increased mitochondrial fission. Interestingly, they found that addition of oleate to PA-treated cells prevented the mitochondrial fission evident with PA alone. Given our previous observation that oleate prevents PA-induced ceramide accrual [8] , the findings by Jheng et al. [5] support ceramide's role as an activator of mitochondrial fission. Further, Jheng et al. [5] observed that Drp1 expression was increased with PA treatment and was an essential mediator of PA-induced mitochcondrial fission. Critically, although we similarly found an increase in Drp1 expression with PA treatment, inhibition of ceramide synthesis blunted the effect ( Figure 2D ).
These studies suggest a paradigm wherein ceramide leads to altered mitochondrial dynamics, with subsequent changes in mitochondrial function, including altered respiration and ROS generation. However, oxidative stress from ROS is among the numerous cellular insults known to induce ceramide biosynthesis [36] , which invites the theory that ROS are both a cause and consequence of the observed mitochondrial dysfunction. To address the possibility that ROS mediate, and thus precede, ceramide-induced changes in mitochondrial function, multiple experiments with ceramide treatment were replicated with the addition of NAC, a glutathione precursor known to reduce levels of H 2 O 2 [22, 23, 39] . Pre-treatment with NAC failed to protect cells from ceramide-induced mitochondrial fission ( Figure 6A ) as well as reduced mitochondrial respiration with both C2 and PA treatment (Figures 6B and 6C) . Altogether, these findings suggest that ROS do not mediate the mitochondria-specific effects of ceramide accumulation.
The site of ceramide biosynthesis in the cells may be relevant in the ability of ceramide to induce mitochondrial fission. Interestingly, the two organelles involved in mitochondrial fission, namely the mitochondria and the ER (endoplasmic reticulum), are two prominent sources of intracellular ceramide [11, 40, 41] . Physical coupling between the ER and mitochondria is necessary for mitochondrial fission, which may explain the somewhat disparate findings that have studied ceramide and mitochondrial function. Previous work that has explored the specific effect of ceramide on mitochondrial respiration has been performed largely, perhaps exclusively, in isolated mitochondria [36, [42] [43] [44] . Our observation of a ceramide-induced reduction in mitochondrial respiration in intact cells and muscle fibres is the first we know of. The different sources and state of the mitochondria (i.e. isolated heart mitochondria compared with mitochondria in permeabilized skeletal muscle cells and fibres) may explain differences in the effects of ceramide on specific aspects of mitochondrial O 2 consumption. In particular, we consistently found a decay in complex II-mediated respiration, whereas Gudz et al. [43] found complex III to be highly affected by ceramide accrual, although complex II involvement in respiration was not determined in that study. Di Paolo et al. [42] , in contrast, found a complex II-specific inhibition of ceramide with state 3 (ADP supported) respiration, which corroborates the findings of the present study ( Figure 3) . It is important to note that given the necessity of physical interaction between the ER and mitochondria for mitochondrial fusion and fission, isolated mitochondria seem to be a less ideal model with which to explore the role of mitochondrial structure in altering mitochondrial respiration. Indeed, we have found that treating isolated heart mitochondria with Mdivi-1 is not effective at preventing a loss of respiration with ceramide (T.S. Tippetts and B.T. Bikman, unpublished work). Given that ceramide reduces respiration in isolated mitochondria [42, 43] , and presumably in the absence of any known fusion-fission events, these observations introduce the possibility of a fissionindependent mechanism. However, we believe our consistent findings in whole cells and muscle fibres that fission is required for ceramide-induced loss of mitochondrial respiration represents the likely physiological event, where changes in mitochondrial structure can occur very rapidly. Indeed, significant mitochondrial fission can occur in minutes in response to PA [5] . Perhaps related to this, we found that waiting 5-10 min was necessary to observe a reduction in respiration in muscle fibre bundles treated with C 16 -ceramide (Figure 4) , which is sufficient time for ceramide to cause mitochondrial fission (Supplementary Figure  S2 at http://www.biochemj.org/bj/456/bj4560427add.htm).
To confirm the specificity of ceramide to modify mitochondrial structure and function, we regularly used dihydroceramide as a negative control. Dihydroceramide (C 2 , C 6 and C 16 in permeabilized muscle fibres and C 2 in permeabilized C2C12 myotubes) had no effect on altering mitochondrial respiration, a finding supported by others [42, 43] . Nevertheless, dihydroceramides, the immediate precursor to ceramides, may regulate respiration. Siddique et al. [45] recently found that cells deficient in Des1 (dihydroceramide desaturase 1), which lack the enzyme that introduces the distinguishing double bond in the sphingolipid backbone, accumulate dihydrosphingolipids, including dihydroceramides, exhibit reduced mitochondrial respiration [45] . A critical difference may be the experimental protocols used in the various studies. Whereas the present study and others [42, 43] , which found no effect of dihydroceramides, used exogenous (and mostly non-biological, e.g. C 2 and C 6 ) dihydroceramides, the results by Siddique et al. [45] were observed under conditions of endogenously altered dihydrosphingolipid levels where a variety of dihydroceramides are increased, including C 18 , C 24 and C 24:1 .
Ceramide has long been known to inhibit insulin signalling via a two-pronged attack on Akt/PKB action, inhibiting Akt/PKB translocation to the cell membrane as well as activating a protein phosphatase that prevents sufficient Akt/PKB phosphorylation [46, 47] . The observation in the present study, and others [5] , of the insulin-sensitizing effect of inhibited mitochondrial fission may lend credence to the theory that redox-sensitive alterations in phosphorylation of proteins relevant in insulin signal transduction may mediate insulin resistance [21] .
Inhibition of ceramide-induced mitochondrial division may have diverse clinical applications, from acutely protecting against ischaemia/reperfusion injury [48] to chronically treating insulin resistance [5] . Ultimately, however, an erroneous assumption from these results would be that mitochondrial fusion is better for the cell than mitochondrial fission. In reality, maintaining freedom for both fusion and fission is a fundamental factor to ensure adequate bioenergetic utility of the mitochondria. The results of the present study suggest that ceramide may prevent the healthy dynamic cycling of mitochondria, essentially forcing sustained fission. Given the relevance of mitochondrial morphology to obesity and insulin resistance/diabetes [29] , these findings add to the mounting obvious applications and benefits of pharmaceutical therapies aimed at preventing excess ceramide biosynthesis. Nonetheless, and importantly, on-going efforts should explore the most effective combination of physical activity and, especially, improved nutritional intervention to prevent excess ceramide accumulation and alleviate subsequent metabolic disruption. 
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Figure S1 Myriocin increases Mnf2 expression
Mfn2 expression was determined in the soleus muscle from mice following a 12 week dietary intervention. Mice receiving myriocin in the SD (SD + Myr) and HFHS diet (HFHS + Myr) groups had significantly higher levels of Mfn2 than groups not receiving myriocin (SD and HFHS alone). *P < 0.05 for myriocin compared with vehicle treatment.
Figure S2 C2 induces rapid mitochondrial fission
C2C12 cells were treated with vehicle (EtOH) or C2 (40μM) for 10 min prior to MitoTracker Red addition and visualization by confocal microscopy.
